Understanding a compound's molecular structure is crucial for advancing research and innovation in industries like pharmaceuticals and biotechnology. For example, studying the structure of the epidermal growth factor receptor (EGFR) allowed researchers to identify binding sites for small-molecule inhibitors, leading to targeted therapies like gefitinib and erlotinib. These developments have significantly improved outcomes for patients with non-small cell lung cancer.